Breast Cancer

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

Breast cancer
Breast cancer
FDA Approves Combination Pack for Treatment of Breast Cancer
05/09/2017
The first combination pack for the treatment of advanced or metastatic breast cancer in postmenopausal women has been approved by the FDA.
05/09/2017
FDA
FDA
FDA Expands Indication for Metastatic Breast Cancer Treatment
04/03/2017
The FDA converted Ibrance to regular FDA approval and approved a supplemental New Drug Application for the drug, broadening its range of antihormonal therapy.
04/03/2017
Breast cancer
Breast cancer
FDA Approves New Option for Advanced or Metastatic Breast Cancer
03/14/2017
The FDA approved ribociclib, taken with an aromatase inhibitor, for the treatment of advanced or metastatic breast cancer in post-menopause women.
03/14/2017